EMEA-001174-PIP02-12-M02

Key facts

Active substance
Turoctocog alfa pegol
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0142/2017
PIP number
EMEA-001174-PIP02-12-M02
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of hereditary factor VIII deficiency
Route(s) of administration
Intravenous use
Contact for public enquiries
Novo Nordisk A/S

Denmark
Tel. +45 44448888
E-mail: paediatrics@novonordisk.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating